Siobhan Sutcliffe, PhD, ScM, MHS
- Phone: 314-362-3788
ScM, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD, (Epidemiology/Infectious disease), 2001
MHS, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (Biostatistics), 2004
PhD, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Epidemiology/Infectious Disease), 2005
Post Doctoral Education
Post-doctoral work, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Epidemiology/Cancer), 2005-7.
Faculty, Master of Population Health Sciences (MPHS) Program
Dr. Sutcliffe is a Professor and Epidemiologist in the Division of Public Health Sciences, Department of Surgery, with a secondary appointment in the Department of Obstetrics and Gynecology. Her research focuses on understanding risk factors for the onset, progression, and/or exacerbation of male and female urologic conditions. These conditions include prostate cancer, benign prostatic hyperplasia (BPH), interstitial cystitis/bladder pain syndrome (IC/BPS), chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS), and other lower urinary tract symptoms (LUTS). Examples of her research include studies of modifiable risk factors for prostate cancer and BPH/LUTS, such as early-life, infectious, and inflammatory exposures; studies of triggers for IC/BPS and CP/CPPS symptom exacerbations; and descriptive studies of female LUTS and bladder health. Dr. Sutcliffe leads investigations on these topics through her role as a Project Leader in the NIDDK-sponsored Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network and Principal Investigator in the NIDDK-sponsored Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium.
In addition to her independent research, Dr. Sutcliffe regularly teams with clinicians, basic scientists, and social scientists to apply her epidemiologic expertise to a diverse array of research studies, including health outcomes studies, therapeutic and preventative clinical trials, mixed-methods studies, comparative effectiveness studies, translational studies, and biomarker studies.
600 S. Taylor Avenue
2nd floor, Rm. 208S, Box 8100
St. Louis, MO 63110